Matches in Nanopublications for { ?s ?p "[In mixed populations of NIS-MSCs and hepatocellular cancer (HCC) cells, clonogenic assays showed a 55% reduction of HCC cell survival after (131)I application.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP259585.RAtGarQ8xC0MtnL3X5yO1e38SAl5Q98JSXw6_d3lPDxN4130_assertion description "[In mixed populations of NIS-MSCs and hepatocellular cancer (HCC) cells, clonogenic assays showed a 55% reduction of HCC cell survival after (131)I application.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP259585.RAtGarQ8xC0MtnL3X5yO1e38SAl5Q98JSXw6_d3lPDxN4130_provenance.
- NP697740.RAV4YewF23fl2JWVComq5B-wzBtCvwzucuYh0AVOH0zGQ130_assertion description "[In mixed populations of NIS-MSCs and hepatocellular cancer (HCC) cells, clonogenic assays showed a 55% reduction of HCC cell survival after (131)I application.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697740.RAV4YewF23fl2JWVComq5B-wzBtCvwzucuYh0AVOH0zGQ130_provenance.
- NP894956.RAHg1IQmcb1THtB0f0isFCHV-KQaegiu_cwL5anK4EMo0130_assertion description "[In mixed populations of NIS-MSCs and hepatocellular cancer (HCC) cells, clonogenic assays showed a 55% reduction of HCC cell survival after (131)I application.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP894956.RAHg1IQmcb1THtB0f0isFCHV-KQaegiu_cwL5anK4EMo0130_provenance.